Endonovo Therapeutics Inc (ENDV)

[Doyle McBoyle1]

Been saying they should be focusing on sofpulse but every time I do that I get some BS reason why we shouldn’t be doing that. This stock is going no where unless these trials go well, it shouldn’t be like that, there should’ve been some type of upswing and held after the distribution agreement but no because endv decided that it’s not the focus and they go completely silent again and what happens, we go right back down to .03. If there was atleast some advertising or anything to get the word to try to generate some revenue I guarantee we’d be in a better position then we are now.